Groll AH - Search Results

1

[Febrile neutropenia in pediatric and adolescent cancer patients].

Bochennek K, Simon A, Laws HJ, Groll AH, Lehrnbecher T. Bochennek K, et al. Among authors: groll ah. Monatsschr Kinderheilkd. 2021;169(5):443-450. doi: 10.1007/s00112-021-01146-4. Epub 2021 Mar 15. Monatsschr Kinderheilkd. 2021. PMID: 33746294 Free PMC article. Review. German.

2

Treatment of fungal infections in neutropenic children.

Lehrnbecher T, Groll AH, Chanock SJ. Lehrnbecher T, et al. Among authors: groll ah. Curr Opin Pediatr. 1999 Feb;11(1):47-55. doi: 10.1097/00008480-199902000-00010. Curr Opin Pediatr. 1999. PMID: 10084084 Review.

3

New antifungal drugs and the pediatric cancer patient: current status of clinical development.

Groll AH, Lehrnbecher T. Groll AH, et al. Klin Padiatr. 2005 May-Jun;217(3):158-68. doi: 10.1055/s-2005-836502. Klin Padiatr. 2005. PMID: 15858708 Review.

4

[Viral infections in pediatric cancer patients].

Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jäger G, Schuster V. Schuster FR, et al. Among authors: groll ah. Klin Padiatr. 2005 Nov;217 Suppl 1:S67-84. doi: 10.1055/s-2005-872519. Klin Padiatr. 2005. PMID: 16288353 Review. German.

5

Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93.

Lehrnbecher T, Kaiser J, Varwig D, Ritter J, Groll AH, Creutzig U, Klingebiel T, Schwabe D. Lehrnbecher T, et al. Among authors: groll ah. Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):735-8. doi: 10.1007/s10096-007-0362-9. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17665231 Clinical Trial.

6

Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey.

Simon A, Lehrnbecher T, Bode U, Groll AH, Tramsen L, Wieland R, Molitor E, Fleischhack G, Laws HJ. Simon A, et al. Among authors: groll ah. Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):801-6. doi: 10.1007/s10096-007-0382-5. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17786491

7

Experiences with the use of caspofungin in paediatric patients.

Lehrnbecher T, Groll AH. Lehrnbecher T, et al. Among authors: groll ah. Mycoses. 2008;51 Suppl 1:58-64. doi: 10.1111/j.1439-0507.2008.01529.x. Mycoses. 2008. PMID: 18471162 Review.

8

Compliance with anti-infective preventive measures: A multicentre survey among paediatric oncology patients.

Lehrnbecher T, Laws HJ, Boehm A, Dworzak M, Janssen G, Simon A, Groll AH. Lehrnbecher T, et al. Among authors: groll ah. Eur J Cancer. 2008 Sep;44(13):1861-5. doi: 10.1016/j.ejca.2008.06.022. Epub 2008 Jul 26. Eur J Cancer. 2008. PMID: 18662870

9

Posaconazole for paediatric patients: status of development and future perspectives.

Groll AH, Lehrnbecher T. Groll AH, et al. Mycoses. 2008 Sep;51 Suppl 2:5-11. doi: 10.1111/j.1439-0507.2008.01569.x. Mycoses. 2008. PMID: 18721328 Review.

10

Safety experience with caspofungin in pediatric patients.

Zaoutis T, Lehrnbecher T, Groll AH, Steinbach WJ, Jafri HS, Maertens J, Ngai AL, Chow JW, Taylor AF, Strohmaier KM, Bourque M, Bradshaw SK, Petrecz M, Kartsonis NA. Zaoutis T, et al. Among authors: groll ah. Pediatr Infect Dis J. 2009 Dec;28(12):1132-5. doi: 10.1097/INF.0b013e3181af5a15. Pediatr Infect Dis J. 2009. PMID: 19779392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page